THE BLOOD VOLUMES AND PLASMA PROTEIN DURING LEVARTERENOL-INDUCED HYPERTENSION

Georgetown University Medical Division, District of Columbia General Hospital, Washington, D. C.

This work was done during the tenure of an Established Investigatorship of the American Heart Association.

This investigation was supported by research grants from: The American Heart Association; The Washington Heart Association, Washington, D. C.; The National Heart Institute (H-2509), National Institutes of Health, Bethesda, Md.; Irwin, Neisler & Co., Decatur, Ill.; Ciba Pharmaceuticals, Inc., Summit, N. J.; and Charles Pfizer & Co., Inc., Brooklyn, N. Y.

Find articles by Finnerty, F. in: JCI | PubMed | Google Scholar

Georgetown University Medical Division, District of Columbia General Hospital, Washington, D. C.

This work was done during the tenure of an Established Investigatorship of the American Heart Association.

This investigation was supported by research grants from: The American Heart Association; The Washington Heart Association, Washington, D. C.; The National Heart Institute (H-2509), National Institutes of Health, Bethesda, Md.; Irwin, Neisler & Co., Decatur, Ill.; Ciba Pharmaceuticals, Inc., Summit, N. J.; and Charles Pfizer & Co., Inc., Brooklyn, N. Y.

Find articles by Buchholz, J. in: JCI | PubMed | Google Scholar

Georgetown University Medical Division, District of Columbia General Hospital, Washington, D. C.

This work was done during the tenure of an Established Investigatorship of the American Heart Association.

This investigation was supported by research grants from: The American Heart Association; The Washington Heart Association, Washington, D. C.; The National Heart Institute (H-2509), National Institutes of Health, Bethesda, Md.; Irwin, Neisler & Co., Decatur, Ill.; Ciba Pharmaceuticals, Inc., Summit, N. J.; and Charles Pfizer & Co., Inc., Brooklyn, N. Y.

Find articles by Guillaudeu, R. in: JCI | PubMed | Google Scholar